Androgenic effects of oral contraceptives: Implications for patient compliance
- 16 January 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (1) , S116-S119
- https://doi.org/10.1016/s0002-9343(99)80069-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimateActa Obstetricia et Gynecologica Scandinavica, 1992
- The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate MetabolismNew England Journal of Medicine, 1990
- A comparative clinical trial of Norinyl 1+35 versus Norinyl 1+50 in Merida, Yucatan, MexicoAdvances in Contraception, 1990
- Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical TrialsActa Obstetricia et Gynecologica Scandinavica, 1990
- Risk of contraceptive discontinuation among adolescentsJournal of Adolescent Health, 1989
- Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- What Do Women Use When They Stop Using the Pill?Family Planning Perspectives, 1987
- Reproductive mortality in the United States: recent trends and methodologic considerations.American Journal of Public Health, 1987
- The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal womenContraception, 1986
- Ovulation Inhibition with Different Doses of Levonorgestrel and Other Progestogens: Clinical and Experimental InvestigationsActa Obstetricia et Gynecologica Scandinavica, 1979